Janux Therapeutics, Inc.

By person

24 insiders · 125 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Avalon Ventures XI, L.P. entity

10% owner

$15.69M (2)

$205.38M (47)

−$189.69M

8,666,664

14.18%

$121.58M

+102.9%

RA CAPITAL MANAGEMENT, L.P. entity

Director

$135.21M (8)

—

+$135.21M

1,060,156

1.73%

$14.87M

—

Lichter Jay

10% owner

$15.69M (2)

$82.30M (4)

−$66.61M

7,826,510

12.80%

$109.80M

—

Reardon Tighe

Acting Chief Financial Officer

$15.69M (2)

$45.04M (2)

−$29.36M

7,992,445

13.07%

$112.13M

+129.3%

Campbell David Alan

President and CEO

—

$6.61M (11) scheduled

−$6.61M

264,742

0.4330%

$3.71M

−20.3%

Meyer Andrew Hollman

Chief Business Officer

—

$4.22M (19) scheduled

−$4.22M

83,095

0.1359%

$1.17M

+18.0%

ORBIMED ADVISORS LLC entity

Director

$12.00M (2)

$10.59M (6)

+$1.41M

513,496

0.8399%

$7.20M

—

Thompson Peter A.

Director

$12.00M (2)

$10.59M (6)

+$1.41M

513,496

0.8399%

$7.20M

—

Bregua Corp entity

10% owner

$999.99K (1)

—

+$999.99K

3,749,250

6.13%

$52.60M

—

DiRaimondo Thomas

Chief Scientific Officer

—

$266.11K (3) scheduled

−$266.11K

155,825

0.2549%

$2.19M

+44.4%

Doyle Janeen Noel

Chief Corp. & Bus. Dev. Ofcr

—

$56.94K (1)

−$56.94K

75,941

0.1242%

$1.07M

—

Dobek Maria

Vice President, Accounting

—

$48.95K (2)

−$48.95K

32,270

0.0528%

$452.72K

+1,038%

McIver Zachariah

Chief Medical Officer

—

$37.26K (1)

−$37.26K

52,286

0.0855%

$733.52K

—

Winter Charles M.

Chief Technical Officer

—

$32.97K (1)

−$32.97K

106,321

0.1739%

$1.49M

+86.1%

Gujrathi Sheila

Director

—

118,889

0.1945%

$1.67M

+13.2%

CAPPS VICKIE L

Director

—

79,598

0.1302%

$1.12M

+24.3%

Go William

Chief Medical Officer

—

44,000

0.0720%

$617.28K

—

Robinson Byron

Chief Strategy Officer

—

28,000

0.0458%

$392.81K

—

DOBMEIER ERIC

Director

—

15,481

0.0253%

$217.18K

—

Hernday Natasha

Director

—

15,481

0.0253%

$217.18K

—

Simson Jake

Director

—

11,750

0.0192%

$164.84K

—

Kung Winston

Director

—

11,750

0.0192%

$164.84K

—

Barrett Ronald W

Director

—

11,750

0.0192%

$164.84K

—

McNulty Alana B.

Director

—

6,250

0.0102%

$87.68K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

RA CAPITAL MANAGEMENT, L.P.

7 Mar 2025

Director

Buy indirect

110,206

$31.02

$3.42M

RA CAPITAL MANAGEMENT, L.P.

6 Mar 2025

Director

Buy indirect

372,093

$30.78

$11.45M

RA CAPITAL MANAGEMENT, L.P.

5 Mar 2025

Director

Buy indirect

37,455

$31.30

$1.17M

RA CAPITAL MANAGEMENT, L.P.

5 Mar 2025

Director

Buy indirect

304,287

$30.56

$9.30M

RA CAPITAL MANAGEMENT, L.P.

18 Oct 2024

Director

Buy indirect

1,200,000

$44.75

$53.70M

Avalon Ventures XI, L.P.

13 Nov 2023

10% owner

Buy indirect

849,854

$5.87

$4.99M

Lichter Jay

13 Nov 2023

Director

Buy indirect

849,854

$5.87

$4.99M

Reardon Tighe

13 Nov 2023

Acting Chief Financial Officer

Buy indirect

849,854

$5.87

$4.99M

RA CAPITAL MANAGEMENT, L.P.

19 Jul 2023

Director

Buy indirect

495,008

$12.46

$6.17M

RA CAPITAL MANAGEMENT, L.P.

15 Jun 2021

Director

Buy indirect

188,986

$17.00

$3.21M

RA CAPITAL MANAGEMENT, L.P.

15 Jun 2021

Director

Buy indirect

2,752,190

$17.00

$46.79M

Avalon Ventures XI, L.P.

15 Jun 2021

10% owner

Buy indirect

629,411

$17.00

$10.70M

Lichter Jay

15 Jun 2021

Director

Buy indirect

629,411

$17.00

$10.70M

Reardon Tighe

15 Jun 2021

Acting Chief Financial Officer

Buy indirect

629,411

$17.00

$10.70M

ORBIMED ADVISORS LLC

15 Jun 2021

Director

Buy indirect

117,650

$17.00

$2.00M

ORBIMED ADVISORS LLC

15 Jun 2021

Director

Buy indirect

588,203

$17.00

$10.00M

Thompson Peter A.

15 Jun 2021

Director

Buy indirect

117,650

$17.00

$2.00M

Thompson Peter A.

15 Jun 2021

Director

Buy indirect

588,203

$17.00

$10.00M

Bregua Corp

15 Jun 2021

10% owner

Buy

58,823

$17.00

$999.99K

Show all 125 transactions →

Janux Therapeutics, Inc.

By person

Individual transactions

What was left out